Pharmacogenomics of Hypertension in CKD: The CKD-PGX Study is a research paper published in Kidney360 (2021). On theSindex it has a DataRank of 0.457. It has been cited 20 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.457
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIH/NIDDK
Grant: K08DK107864
NIH/NIDDK
Grant: R01DK11087103
NIH/NIDDK
Grant: K23DK102824
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: P30AR072581-01
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: R01AR077273
National Institutes of Health
Grant: 1P30AR072581-01
Indiana Core Center for Clinical Research in Musculoskeletal Health
National Institutes of Health
Grant: 5K08DK107864-05
Acute inhibition of renal gene expression to prevent nephrotoxicity.
National Institutes of Health
Grant: 5K23DK102824-04
Longitudinal Assessment of Skeletal Muscle Physiology in Dialysis Patients
National Institutes of Health
Grant: 5R01AR077273-03
Sarcopenia: computable phenotypes and clinical outcomes.
FWCI
2.70
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals